Join to access to all OVN content. Join for Free

Results for 'pharmaceutical sales'

...
Partner Avatar Michael Pietrack
Leading From the Front: 3 Leadership Lessons From Mark Cuban

Dec 17th • 6 mins read

...
Partner Avatar Michael Pietrack
Leadership Lab: 5 Ways Biopharma Execs Can Restore Trust, Retain Talent After Layoffs

Jun 25th • 4 mins read

...
Partner Avatar Michael Pietrack
Leadership Lab: 4 Ways Biopharma Leaders Can Prepare for Media Interviews

Aug 20th • 6 mins read

...
Partner Avatar Michael Pietrack
Managing Emotions After Being Downsized

Oct 21st • 5 mins read

...
Partner Avatar Michael Pietrack
Practical Advice for When You're Downsized. What Activities will Pay-off after a Lay-off?

Sep 15th • 5 mins read

...
Partner Avatar Michael Pietrack
Resume Advice: Tattoos and Breadcrumbs

Jul 14th • 5 mins read

...
Partner Avatar Michael Pietrack
What Do Tennis and Job Interviewing Have in Common?

Apr 14th • 5 mins read

...
Partner Avatar Michael Pietrack
Hiring Managers: What Should You Do During a Hiring Freeze?

Jan 26th • 5 mins read

...
OVN Avatar Forbes Books Press Release Official
New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures

Sep 9th • 5 mins read

...
Partner Avatar Tom Caravela
“Extreme Interviewing” – MSL Interview Tips and Insights from Medical Affairs Leaders

Jul 9th • 1 min read

...
Partner Avatar Tom Caravela
Job Search Checklist for Aspiring Medical Science Liaisons

May 17th • 2 mins read

...
Partner Avatar Tom Caravela
Resume Writing and Editing Tips for Pharma Professionals

Aug 8th • 1 min read

...
Partner Avatar Tom Caravela
MSL Evolution: New Trends and Titles That May Emerge

Apr 5th • 1 min read

...
Partner Avatar Tom Caravela
MSL People Skills: Top 10 Tips for Better Engagement

Apr 20th • 8 mins read

...
Partner Avatar Tom Caravela
Promotability: How to Land Your Next Promotion

May 5th • 10 mins read

...
Partner Avatar Tom Caravela
What to do When a Job Offer is Rescinded

Jul 20th • 5 mins read

...
OVN Avatar Charles L. Bennett , Sumimasa Nagai , Andrew C. Bennett , Shamia Hoque , Chadi Nabhan , Martin W. Schoen , William J. Hrushesky , Stefano Luminari , Paul Ray , Paul R. Yarnold , Bart Witherspoon , Josh Riente , Laura Bobolts , John Brusk , Rebecca Tombles
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions

Mar 12th • 7 mins read

...
OVN Avatar Thakur, Sayanta & Lahiry, Sandeep
Accelerated drug approvals in oncology: Pros and cons

Sep 14th • 4 mins read

...
OVN Avatar Stefanie Broes, Robbe Saesen, Denis Lacombe, Isabelle Huys
Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer

Aug 16th • 8 mins read

...
OVN Avatar Cornelius F Waller & Adriano Friganovi´c
Biosimilars in oncology: key role of nurses in patient education

Jun 15th • 10 mins read

Related Topics

Loading...